4Wang S C.Trends in nuclear medicine in developing countries by inference from experience in China[J].Paper Presented at IAEA RCA Seminar, 2011, 9(3): 76.
5Dehdashti F, Grigsby P W, Mintun M A, et al.Assessing turn orhypoxia in ceryicalby position emission tomography with 60Cu-ATSM : relationship to therapeutic response a prelm inary report[J].Int JRadiat Oncol Biol Phys, 2013, 55(5): 1233-1238.
8Marcos H B, Libutti S K, Alexander H R, et al.Neuroendoerine tumors of the pancreas in von Hippel-Lindau disease; spectrum of appearance at CT and MR imaging of with histopathologie com-parison[J].Radiology, 2012, 225(3): 751-758.
10Vries E F, RotsM G, Hospers G A.Nuclear imaging of hormonal receptor status in breastcancer: a tool forguiding endocrine treat-ment and drug development[J].Curr Cancer Drug Targets, 2012, 7(6): 510-519.
9Tian JH, Yang XF, Yu LJ, et al. A muhicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-^18F-fluorothymidine and ^18F-FDG. J Nucl Med, 2008, 49 : 186-194.
10Wagnar NH. From molecular imaging to molecular medicine. J Nucl Mecl, 2006: 13N-39N.
